Inventor · disambiguated record
Stanley Krystek
Also filed as: KRYSTEK JR STANLEY R · KRYSTEK JR STANLEY RICHARD · KRYSTEK STANLEY · KRYSTEK STANLEY R
33 granted patents·14 pending applications·265 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
47 records- 0196US11926673B2Antagonistic CD40 monoclonal antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 12, 2024·4 cites·18 claims
- 0296US11254750B2Antagonistic CD40 monoclonal antibodies and uses in treating immune responsesBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 22, 2022·6 cites·25 claims
- 0396US8853154B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 7, 2014·35 cites·15 claims
- 0495US6960474B2Method for the treatment of a condition remediable by administration of a selective androgen receptor modulatorBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 1, 2005·82 cites·8 claims
- 0594US12419953B2Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodiesBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Sep 23, 2025·1 cites·20 claims
- 0694US11795231B2Antagonistic CD40 monoclonal antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Oct 24, 2023·2 cites·23 claims
- 0794US11773178B2Antagonistic CD40 monoclonal antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Oct 3, 2023·2 cites·17 claims
- 0893US9493546B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·14 cites·20 claims
- 0993US8945553B2Bispecific antibodies to IL-23 and IL-17A/FBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Feb 3, 2015·16 cites·12 claims
- 1092US11434275B2Fast-off rate serum albumin binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Sep 6, 2022·3 cites·18 claims
- 1191US9475879B2Antibody polypeptides that antagonize CD40SURI ANISH·Filed 2012·Granted Oct 25, 2016·31 cites·15 claims
- 1288US11524992B2Glypican-3-binding fibronectin based scaffold moleculesBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 13, 2022·2 cites·12 claims
- 1388US7705134B2Antibodies that bind to BGS-4BRISTOL MYERS SQUIBB CO·Filed 2008·Granted Apr 27, 2010·9 cites·1 claims
- 1488US7223558B2Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereofBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 29, 2007·27 cites·8 claims
- 1587US10766946B2Fast-off rate serum albumin binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 8, 2020·4 cites·11 claims
- 1687US2024316161A1Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1786US12409223B2Antagonistic CD40 monoclonal antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Sep 9, 2025·0 cites·18 claims
- 1885US11261258B2Antagonistic CD40 monoclonal antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 1, 2022·2 cites·14 claims
- 1983US7456256B2Bgs 4BRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 25, 2008·5 cites·2 claims
- 2081US11623965B2Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 11, 2023·1 cites·11 claims
- 2181US10584160B2Glypican-3-binding fibronectin based scaffold moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 10, 2020·3 cites·22 claims
- 2278US12492238B2Glypican-3-binding fibronectin based scaffold moleculesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 9, 2025·0 cites·6 claims
- 2378US10245302B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·17 claims
- 2477US11813315B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 14, 2023·0 cites·20 claims
- 2577US6795776B1Crystallographic structure of the androgen receptor ligand binding domainBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Sep 21, 2004·12 cites·3 claims
- 2676US10787498B2Fibronectin type III domain proteins with enhanced solubilityBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 29, 2020·1 cites·3 claims
- 2775US9783606B2Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodiesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 10, 2017·1 cites·71 claims
- 2873US10544228B2Nucleic acids encoding antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 2972US2023145413A1Fast-off rate serum albumin binding fibronectin type iii domainsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3071US2023295346A1Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3170US11512124B2Fibronectin type III domain proteins with enhanced solubilityBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 29, 2022·0 cites·10 claims
- 3266US10358490B2Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodiesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·0 cites·18 claims
- 3364US11136406B2Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 3462US2004048302A1Novel metalloprotease polypeptide, MP-1Filed 2003·Application pending·0 cites
- 3560US2004043407A1Polynucleotides encoding a novel metalloprotease, MP-1Filed 2003·Application pending·0 cites
- 3653US2005118632A1Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40bFiled 2004·Application pending·0 cites
- 3752US12065505B2Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 3851US7811787B2Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3BRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 12, 2010·0 cites·20 claims
- 3951US7225083B2Crystallographic structure of the androgen receptor ligand binding domainBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 29, 2007·0 cites·8 claims
- 4048US2005256048A1Selective androgen receptor modulators and methods for their identification, design and useSALVATI MARK E·Filed 2005·Application pending·0 cites
- 4147US2004204576A1Polynucleotides encoding a novel human phosphatase, BMY_HPP13Filed 2003·Application pending·0 cites
- 4247US2003204070A1Polynucleotide encoding a novel methionine aminopeptidase, protease-39Filed 2003·Application pending·0 cites
- 4347US2006235028A1Inhibitors of 11-beta hydroxysteroid dehydrogenase type ILI JAMES J·Filed 2006·Application pending·0 cites
- 4446US2004033506A1Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereofFiled 2002·Application pending·0 cites
- 4544US2011077395A1Inhibitors of 11-beta hydroxysteroid dehydrogenase type iBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 4642US2003114354A1Polynucleotide encoding a novel potassium channel with homology to the ether-a-go-go family, HEAG2Filed 2002·Application pending·0 cites
- 4734US2002068346A1Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stanley Krystek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →